{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:51:08Z","timestamp":1791409868615,"version":"4.3.3"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T00:00:00Z","timestamp":1754697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T00:00:00Z","timestamp":1754697600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Lundbeck"},{"DOI":"10.13039\/501100007052","name":"Universit\u00e0 degli Studi di Verona","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007052","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Different mechanisms are involved in migraine pathogenesis, including neurogenic inflammation, neurodegenerative processes, and a potential role of microglia. The aim of this study was to assess axonal and glial damage measuring serum levels of neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP) in migraine patients. Serum samples of 25 patients with episodic migraine (EM), 25 with chronic migraine (CM\n                    <jats:bold>)<\/jats:bold>\n                    diagnosed in accordance with the International Classification of Headache Disorders, 3rd edition (ICHD-3), and 50 age-matched healthy controls were prospectively collected. NfL and GFAP levels were assessed using ultrasensitive paramagnetic bead-based ELISA (SIMOA). Non-parametric tests were used for group comparison and 2-tailed Spearman analysis to assess correlations. GFAP levels were significantly increased in migraine patients (median 103.15\u00a0pg\/mL [\n                    <jats:italic>IQR<\/jats:italic>\n                    70.98\u2013146.34] vs. 69.43\u00a0pg\/mL [\n                    <jats:italic>IQR<\/jats:italic>\n                    53.04\u201391.85],\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001), particularly in those with medication overuse (106.08 [\n                    <jats:italic>IQR<\/jats:italic>\n                    87.94\u2013159.07] vs. 71.38 [\n                    <jats:italic>IQR<\/jats:italic>\n                    54.16\u2013135.06],\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.007), without difference between EM and CM (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.985). Although NfL levels were not increased (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.387), they were higher in patients with a long migraine course (rho 0.519,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001). Attack at sampling\/days from last attack, migraine frequency\/attack severity did not influence NfL or GFAP levels. Our findings demonstrate the occurrence of glial damage, particularly correlated with medication overuse, and the presence of axonal damage in the later disease stage, providing potential novel cues for the migraine pathogenesis.\n                  <\/jats:p>","DOI":"10.1007\/s12026-025-09674-x","type":"journal-article","created":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T01:10:58Z","timestamp":1754701858000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["GFAP as a marker of astrocytic damage correlated with medication overuse in migraine"],"prefix":"10.1007","volume":"73","author":[{"given":"Sara","family":"Carta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Chiodega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Tiberi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Pasquali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Bozzetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Ranieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Marchioretto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Mariotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,9]]},"reference":[{"key":"9674_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/S10194-019-0985-0","author":"A Straube","year":"2019","unstructured":"Straube A, Andreou A. Primary headaches during lifespan. J Headache Pain. 2019. https:\/\/doi.org\/10.1186\/S10194-019-0985-0.","journal-title":"J Headache Pain"},{"key":"9674_CR2","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1016\/S0140-6736(20)32162-0","volume":"397","author":"M Ashina","year":"2021","unstructured":"Ashina M, Terwindt GM, Al-Karagholi MAM, et al. Migraine: disease characterisation, biomarkers, and precision medicine. Lancet. 2021;397:1496\u2013504. https:\/\/doi.org\/10.1016\/S0140-6736(20)32162-0.","journal-title":"Lancet"},{"key":"9674_CR3","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1056\/NEJMRA1915327","volume":"383","author":"M Ashina","year":"2020","unstructured":"Ashina M. Migraine. N Engl J Med. 2020;383:1866\u201376. https:\/\/doi.org\/10.1056\/NEJMRA1915327.","journal-title":"N Engl J Med"},{"key":"9674_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/BIOMEDICINES10010076","author":"E Spekker","year":"2021","unstructured":"Spekker E, Tanaka M, Szab\u00f3 \u00c1, V\u00e9csei L. Neurogenic inflammation: the participant in migraine and recent advancements in translational research. Biomedicines. 2021. https:\/\/doi.org\/10.3390\/BIOMEDICINES10010076.","journal-title":"Biomedicines"},{"key":"9674_CR5","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1111\/HEAD.14740","volume":"64","author":"HC Cropper","year":"2024","unstructured":"Cropper HC, Conway CM, Wyche W, Pradhan AA. Glial activation in pain and emotional processing regions in the nitroglycerin mouse model of chronic migraine. Headache. 2024;64:973\u201382. https:\/\/doi.org\/10.1111\/HEAD.14740.","journal-title":"Headache"},{"key":"9674_CR6","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/J.1468-2982.2009.01904.X","volume":"30","author":"MC Kruit","year":"2010","unstructured":"Kruit MC, Van Buchem MA, Launer LJ, et al. Migraine is associated with an increased risk of deep white matter lesions, subclinical posterior circulation infarcts and brain iron accumulation: the population-based MRI CAMERA study. Cephalalgia. 2010;30:129\u201336. https:\/\/doi.org\/10.1111\/J.1468-2982.2009.01904.X.","journal-title":"Cephalalgia"},{"key":"9674_CR7","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/s41583-019-0218-1","volume":"20","author":"RR Ji","year":"2019","unstructured":"Ji RR, Donnelly CR, Nedergaard M. Astrocytes in chronic pain and itch. Nat Rev Neurosci. 2019;20:667\u201385. https:\/\/doi.org\/10.1038\/s41583-019-0218-1.","journal-title":"Nat Rev Neurosci"},{"key":"9674_CR8","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1177\/0333102417702132","volume":"38","author":"A Ghaemi","year":"2018","unstructured":"Ghaemi A, Alizadeh L, Babaei S, et al. Astrocyte-mediated inflammation in cortical spreading depression. Cephalalgia. 2018;38:626\u201338. https:\/\/doi.org\/10.1177\/0333102417702132.","journal-title":"Cephalalgia"},{"key":"9674_CR9","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/J.JOCN.2020.10.046","volume":"82","author":"S Yilmaz","year":"2020","unstructured":"Yilmaz S. Serum NO, S100B, NSE concentrations in migraine and their relationship. J Clin Neurosci. 2020;82:32\u20135. https:\/\/doi.org\/10.1016\/J.JOCN.2020.10.046.","journal-title":"J Clin Neurosci"},{"key":"9674_CR10","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/ANE.13365","volume":"143","author":"M G\u00f6nen","year":"2021","unstructured":"G\u00f6nen M, \u00d6zdo\u011fan S, Balgetir F, et al. S100B and neuron-specific enolase levels in episodic and chronic migraine. Acta Neurol Scand. 2021;143:298\u2013302. https:\/\/doi.org\/10.1111\/ANE.13365.","journal-title":"Acta Neurol Scand"},{"key":"9674_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2018-320106","author":"L Gaetani","year":"2019","unstructured":"Gaetani L, Blennow K, Calabresi P, et al. Neurofilament light chain as a biomarker in neurological disorders. J Neurol Neurosurg Psychiatry. 2019. https:\/\/doi.org\/10.1136\/jnnp-2018-320106.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9674_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-023-01674-2","author":"J Fang","year":"2023","unstructured":"Fang J, Wu J, Zhang T, et al. Serum neurofilament light chain levels in migraine patients: a monocentric case\u2013control study in China. J Headache Pain. 2023. https:\/\/doi.org\/10.1186\/s10194-023-01674-2.","journal-title":"J Headache Pain"},{"key":"9674_CR13","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1111\/HEAD.13919","volume":"60","author":"N Riesco","year":"2020","unstructured":"Riesco N, Cernuda-Moroll\u00f3n E, Mart\u00ednez-Camblor P, et al. Peripheral, interictal serum s100b levels are not increased in chronic migraine patients. Headache. 2020;60:1705\u201311. https:\/\/doi.org\/10.1111\/HEAD.13919.","journal-title":"Headache"},{"key":"9674_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/FNEUR.2022.914051","author":"C Chu","year":"2022","unstructured":"Chu C, Zhong R, Cai M, et al. Elevated blood S100B levels in patients with migraine: a systematic review and meta-analysis. Front Neurol. 2022. https:\/\/doi.org\/10.3389\/FNEUR.2022.914051.","journal-title":"Front Neurol"},{"key":"9674_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-024-01757-8","author":"M S\u00fc\u00dfe","year":"2024","unstructured":"S\u00fc\u00dfe M, Kloetzer C, Strau\u00df S, et al. Increased CX3CL1 in cerebrospinal fluid and ictal serum t-tau elevations in migraine: results from a cross-sectional exploratory case-control study. J Headache Pain. 2024. https:\/\/doi.org\/10.1186\/s10194-024-01757-8.","journal-title":"J Headache Pain"},{"key":"9674_CR16","doi-asserted-by":"publisher","DOI":"10.1177\/03331024251338178","author":"E Gozalov","year":"2025","unstructured":"Gozalov E, Karlsson WK, Christensen RH, et al. Serum GFAP and NfL levels in migraine: a registry for migraine (REFORM) study. Cephalalgia. 2025. https:\/\/doi.org\/10.1177\/03331024251338178.","journal-title":"Cephalalgia"},{"key":"9674_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-023-01663-5","author":"LH Overeem","year":"2023","unstructured":"Overeem LH, Raffaelli B, Fleischmann R, et al. Serum tau protein elevation in migraine: a cross-sectional case\u2013control study. J Headache Pain. 2023. https:\/\/doi.org\/10.1186\/s10194-023-01663-5.","journal-title":"J Headache Pain"},{"key":"9674_CR18","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1007\/S10072-025-08011-2","volume":"46","author":"E Colombo","year":"2025","unstructured":"Colombo E, Doretti A, Rao R, et al. Plasma levels of glial fibrillary acidic protein and neurofilament light chain in patients with chronic migraine: a multicenter case-control study. Neurol Sci. 2025;46:2209\u201316. https:\/\/doi.org\/10.1007\/S10072-025-08011-2.","journal-title":"Neurol Sci"},{"key":"9674_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/0333102417738202","volume":"38","author":"J Olesen","year":"2018","unstructured":"Olesen J. Headache Classification Committee of the International Headache Society (IHS) The International Classification of headache disorders. Cephalalgia. 2018;38:1\u2013211. https:\/\/doi.org\/10.1177\/0333102417738202.","journal-title":"Cephalalgia"},{"key":"9674_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s10194-024-01755-w","volume":"25","author":"H Gosalia","year":"2024","unstructured":"Gosalia H, Moreno-Ajona D, Goadsby PJ. Medication-overuse headache: a narrative review. J Headache Pain. 2024;25:1\u20139. https:\/\/doi.org\/10.1186\/s10194-024-01755-w.","journal-title":"J Headache Pain"},{"key":"9674_CR21","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1007\/S00415-019-09306-Z","volume":"266","author":"S Mariotto","year":"2019","unstructured":"Mariotto S, Gajofatto A, Zuliani L, et al. Serum and CSF neurofilament light chain levels in antibody-mediated encephalitis. J Neurol. 2019;266:1643\u20138. https:\/\/doi.org\/10.1007\/S00415-019-09306-Z.","journal-title":"J Neurol"},{"key":"9674_CR22","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200188\/ASSET\/5BB203B6-8562-49D1-B5A5-73A9A77AF150","volume":"11","author":"S Carta","year":"2023","unstructured":"Carta S, Dinoto A, Capobianco M. Serum biomarker profiles discriminate AQP4 seropositive and double seronegative neuromyelitis optica spectrum disorder. Neurol Neuroimmunol Neuroinflamm. 2023;11: e200188. https:\/\/doi.org\/10.1212\/NXI.0000000000200188\/ASSET\/5BB203B6-8562-49D1-B5A5-73A9A77AF150.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"9674_CR23","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1515\/CCLM-2022-0646","volume":"60","author":"L Tybirk","year":"2022","unstructured":"Tybirk L, Hviid CVB, Knudsen CS, Parkner T. Serum GFAP - reference interval and preanalytical properties in Danish adults. Clin Chem Lab Med. 2022;60:1830\u20138. https:\/\/doi.org\/10.1515\/CCLM-2022-0646.","journal-title":"Clin Chem Lab Med"},{"key":"9674_CR24","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1080\/00365513.2020.1730434","volume":"80","author":"CVB Hviid","year":"2020","unstructured":"Hviid CVB, Knudsen CS, Parkner T. Reference interval and preanalytical properties of serum neurofilament light chain in Scandinavian adults. Scand J Clin Lab Invest. 2020;80:291\u20135. https:\/\/doi.org\/10.1080\/00365513.2020.1730434.","journal-title":"Scand J Clin Lab Invest"},{"issue":"5","key":"9674_CR25","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1002\/ana.26067","volume":"89","author":"O Aktas","year":"2021","unstructured":"Aktas O, Smith MA, Rees WA, et al. Serum glial fibrillary acidic protein\u202f: a neuromyelitis optica spectrum disorder biomarker. Ann Neurol. 2021;89(5):895\u2013910. https:\/\/doi.org\/10.1002\/ana.26067.","journal-title":"Ann Neurol"},{"key":"9674_CR26","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/S41582-021-00616-3","volume":"18","author":"A Abdelhak","year":"2022","unstructured":"Abdelhak A, Foschi M, Abu-Rumeileh S, et al. Blood GFAP as an emerging biomarker in brain and spinal cord disorders. Nat Rev Neurol. 2022;18:158\u201372. https:\/\/doi.org\/10.1038\/S41582-021-00616-3.","journal-title":"Nat Rev Neurol"},{"key":"9674_CR27","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/S00281-018-0676-Y","volume":"40","author":"R Ramachandran","year":"2018","unstructured":"Ramachandran R. Neurogenic inflammation and its role in migraine. Semin Immunopathol. 2018;40:301\u201314. https:\/\/doi.org\/10.1007\/S00281-018-0676-Y.","journal-title":"Semin Immunopathol"},{"key":"9674_CR28","doi-asserted-by":"publisher","DOI":"10.1126\/SCIADV.AAZ1584","author":"J Romanos","year":"2020","unstructured":"Romanos J, Romanos J, Benke D, et al. Astrocyte dysfunction increases cortical dendritic excitability and promotes cranial pain in familial migraine. Sci Adv. 2020. https:\/\/doi.org\/10.1126\/SCIADV.AAZ1584.","journal-title":"Sci Adv"},{"key":"9674_CR29","doi-asserted-by":"publisher","first-page":"6005","DOI":"10.3390\/IJMS21176005","volume":"21","author":"S Afroz","year":"2020","unstructured":"Afroz S, Arakaki R, Iwasa T, et al. Role of CGRP in neuroimmune interaction via NF-\u03baB signaling genes in glial cells of trigeminal ganglia. Int J Mol Sci. 2020;21:6005. https:\/\/doi.org\/10.3390\/IJMS21176005.","journal-title":"Int J Mol Sci"},{"key":"9674_CR30","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1111\/J.1468-2982.2006.01183.X","volume":"26","author":"I Ayzenberg","year":"2006","unstructured":"Ayzenberg I, Obermann M, Nyhuis P, et al. Central sensitization of the trigeminal and somatic nociceptive systems in medication overuse headache mainly involves cerebral supraspinal structures. Cephalalgia. 2006;26:1106\u201314. https:\/\/doi.org\/10.1111\/J.1468-2982.2006.01183.X.","journal-title":"Cephalalgia"},{"key":"9674_CR31","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/NRNEUROL.2016.124","volume":"12","author":"HC Diener","year":"2016","unstructured":"Diener HC, Holle D, Solbach K, Gaul C. Medication-overuse headache: risk factors, pathophysiology and management. Nat Rev Neurol. 2016;12:575\u201383. https:\/\/doi.org\/10.1038\/NRNEUROL.2016.124.","journal-title":"Nat Rev Neurol"},{"key":"9674_CR32","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S0039-6109(05)70381-9","volume":"79","author":"J Katz","year":"1999","unstructured":"Katz J, Melzack R. Measurement of pain. Surg Clin North Am. 1999;79:231\u201352. https:\/\/doi.org\/10.1016\/S0039-6109(05)70381-9.","journal-title":"Surg Clin North Am"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-025-09674-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12026-025-09674-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-025-09674-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T07:29:23Z","timestamp":1770190163000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12026-025-09674-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,9]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["9674"],"URL":"https:\/\/doi.org\/10.1007\/s12026-025-09674-x","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"value":"0257-277X","type":"print"},{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,9]]},"assertion":[{"value":"5 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards\u00a0"}},{"value":"Sara Mariotto received speaker honoraria from Horizon, UCB, Novartis, Biogen, Sanofi, Alexion, Roche, TSF, Dynamics.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"119"}}